Illumina Stock News

U.S. life sciences company Illumina could face a hefty fine for jumping the gun by completing its $8 billion cash-and-stock takeover of cancer detection test maker Grail without first securing EU anti

Shares of Illumina Inc. ILMN, -9.86% tumbled 9.8% in afternoon trading Thursday, enough to pace the S&P 500's SPX, +0.01% decliners, after the life sciences tools disclosed that it is likely to be fin

In defiance of FTC and EU scrutiny, Illumina Inc (NASDAQ: ILMN) went ahead to complete its $8 billion acquisition of Grail. The finalization of the buyout comes as the FTC sued to block the move i

Illumina Inc has completed its $7.1 billion acquisition of cancer detection test maker Grail Inc, it said on Wednesday amid challenges posed by the U.S. Federal Trade Commission and the European Union

SAN DIEGO, Aug. 18, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, b

According to CEO Francis deSouza, the genetic life-sciences company is "firing on all cylinders."

The European Commission has temporarily suspended the provisional deadline for its investigation into Illumina Inc's (NASDAQ: ILMN) plans to buy Grail Inc, adding uncertainty to whether regulators

The leader in the genomics space is being treated like a monopoly, and is now running into federal regulation and oversight.

The genomics leader might be hitting a ceiling in its original business.

Year-over-year improvement in segmental revenues in Q2 across all geographies exceeds Illumina's (ILMN) expectations.

Illumina will likely be allowed to buy Grail. But even without that deal, ILMN stock is very attractive, given the company's strong growth drivers.

Illumina Inc (NASDAQ: ILMN) reported after the close of the market on Thursday that its second-quarter revenues grew 78% Y/Y to $1.13 billion, beating the consensus of $1.01 billion, driven by stren

Illumina's (ILMN) CEO Francis deSouza on Q2 2021 Results - Earnings Call Transcript

Illumina (ILMN) delivered earnings and revenue surprises of 37.50% and 11.26%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Shares of Illumina (NASDAQ:ILMN) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 201.61% over the past year to $1.87, which beat